In response: Drug-resistant epilepsy in adults: outcome trajectories after failure of two medications
Epilepsia
.
2016 Sep;57(9):1526-7.
doi: 10.1111/epi.13487.
Authors
Hyunmi Choi
1
,
Matthew J Hayat
2
,
Ruiqi Zhang
3
,
Lawrence J Hirsch
4
,
Carl Bazil
5
,
Anil Mendiratta
5
,
Kenneth Kato
5
,
Asif Javed
5
,
Alexander W Legge
5
,
Richard Buchsbaum
6
,
Stanley Resor
,
Gary Heiman
7
Affiliations
1
Department of Neurology, Columbia University, New York, New York, U.S.A.. hc323@columbia.edu.
2
School of Public Health, Georgia State University, Atlanta, Georgia, U.S.A.
3
Department of Applied Mathematics and Statistics, State University of New York at Stony Brook, Stony Brook, New York, U.S.A.
4
Department of Neurology, Yale University, New Haven, Connecticut, U.S.A.
5
Department of Neurology, Columbia University, New York, New York, U.S.A.
6
Department of Biostatistics, Mailman School of Public Health at Columbia University, New York, New York, U.S.A.
7
Department of Genetics, The Human Genetics Institute of New Jersey, Rutgers, the State University of New Jersey, Piscataway, New Jersey, U.S.A.
PMID:
27594402
DOI:
10.1111/epi.13487
No abstract available
Publication types
Letter
Comment
MeSH terms
Adult
Anticonvulsants*
Drug Resistance
Drug Resistant Epilepsy*
Epilepsy
Humans
Treatment Outcome
Substances
Anticonvulsants